GABAergic circuits in the basal ganglia and movement disorders
Authors:
- 1 January 2007
- book chapter
- Published by Elsevier
- Vol. 160, 287-312
Abstract
No abstract availableKeywords
This publication has 251 references indexed in Scilit:
- New therapies for the treatment of Parkinson's disease: Adenosine A2A receptor antagonistsLife Sciences, 2005
- Human neural stem cell transplants improve motor function in a rat model of Huntington's diseaseJournal of Comparative Neurology, 2004
- Vascular hemichorea/hemiballism and topiramateMovement Disorders, 2004
- Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's diseaseMovement Disorders, 2002
- Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's diseaseMovement Disorders, 2002
- Hemiballism after subthalamotomy in patients with Parkinson's disease: Report of 2 casesMovement Disorders, 2002
- Benzodiazepine receptor binding in Huntington's disease: [11C]Flumazenil uptake measured using positron emission tomographyAnnals of Neurology, 2000
- Partial Restoration of Striatal GABAA Receptor Balance by Functional Mesencephalic Dopaminergic Grafts in Mice with Hereditary ParkinsonismExperimental Neurology, 1999
- Huntington's disease: Studies on brain free amino acidsLife Sciences, 1988
- Huntington'S disease: Treatment with muscimol, A GABA‐mimetic drugAnnals of Neurology, 1978